Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors.
Pedraza-Arevalo S, Alors-Pérez E, Blázquez-Encinas R, Herrera-Martínez AD, Jiménez-Vacas JM, Fuentes-Fayos AC, Reyes Ó, Ventura S, Sánchez-Sánchez R, Ortega-Salas R, Serrano-Blanch R, Gálvez-Moreno MA, Gahete MD, Ibáñez-Costa A, Luque RM, Castaño JP.
Pedraza-Arevalo S, et al.
Transl Res. 2023 Jan;251:63-73. doi: 10.1016/j.trsl.2022.07.005. Epub 2022 Jul 24.
Transl Res. 2023.
PMID: 35882361